CLDF Title
Home | Contact Us | Bookmark
 
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
 
Back Drug & Device Development  
 
Available Topics
06-05-2013 Anti-HBV vaccine fails against chronic hepatitis B
06-04-2013 Blood tests diagnose fibrosis, cirrhosis in chronic hepatitis C
05-07-2013 Antivirals effective against HBV post liver transplant, without HBIG
05-03-2013 Early HCV response more likely with peg-interferon alpha-2a than -2b
05-02-2013 Combo hepatitis C pill shown effective in small mid-stage trial
04-23-2013 Interferon may curb recurrence of liver cancer
04-23-2013 Bristol-Myers oral HCV regimen looks competitive in phase II trial
04-23-2013 New AbbVie drugs cure hepatitis C at eight weeks
04-08-2013 High-intensity focused ultrasound compares favorably with RFA for recurrent hepatoma
03-27-2013 Early test of micro-RNA-targeting drug shows promise against HCV
03-19-2013 Phlebotomy might help in fatty liver disease
03-15-2013 Device keeps liver "alive" outside the body in medical first
03-08-2013 Leptin helpful in non-alcoholic steatohepatitis
03-08-2013 For adefovir nephrotoxicity, just lower the dose
02-19-2013 Sofosbuvir for Hep C drug meets main goal of fourth late-stage study
02-04-2013 Two hepatitis C drug trials meet study goals
01-31-2013 Experimental liver cancer therapy fails in late-stage trial
12-06-2012 Sorafenib can be combined with arterial embolization for treating liver tumors
12-06-2012 Early response points to boceprevir combo success in HCV
12-05-2012 HCV response to IFN/ribavirin hints at response to telaprevir
11-29-2012 Liraglutide safe, effective in type 2 diabetics with liver injury
11-27-2012 Hepatitis C drug shows promise in late-stage trial
11-12-2012 Boehringer Ingelheim to start late-stage hepatitis C drug trial
11-12-2012 Novartis' Certican succeeds in liver transplant trial
11-12-2012 Abbott hepatitis C drugs bring high cure rates in trial
10-25-2012 Telaprevir, boceprevir offer similar efficacy for most patients with HCV 1
10-15-2012 Rapid and point-of-care tests accurately diagnose hepatitis C
09-27-2012 Gemcitabine-oxaliplatin combo effective in advanced liver cancer
09-25-2012 Vertex ends work on one hepatitis C drug, continues another
09-03-2012 Raloxifene aids HCV therapy in some postmenopausal women
08-01-2012 Doxorubicin-eluting beads improve HCC outcomes
07-30-2012 High-dose ribavirin plus EPO no extra help against HCV in HIV
07-25-2012 Low-dose flutamide doesn't eliminate hepatotoxicity risk
07-16-2012 Prophylactic antidepressant may ward off interferon blues
07-13-2012 Long-term entecavir effective for chronic HBV
07-11-2012 Sorafenib beneficial in liver cancer regardless of etiology
06-07-2012 Some rapid hep B screening tests highly accurate
05-31-2012 Bristol urges combo study with Gilead hepatitis drug
04-19-2012 Dramatic data for Gilead, Bristol hepatitis C drugs
04-19-2012 Telaprevir may cause severe cutaneous eruptions
04-11-2012 Tremelimumab shows promise in patients with liver cancer
04-04-2012 Abbott hepatitis C combo impressive in small study
03-06-2012 Vertex, Merck hepatitis drugs work in HIV patients
03-06-2012 More patients relapse in Gilead hepatitis C trial
02-24-2012 Gilead hepatitis C setback opens door to rivals
02-21-2012 Noradrenaline a cost-effective option for type 1 hepatorenal syndrome
02-20-2012 Vandetanib shows limited clinical activity in inoperable hepatocellular carcinoma
02-17-2012 Some patients in hep C trial show relapse: Gilead
02-14-2012 Tyrosine kinase inhibitors linked to increased treatment-related mortality
02-10-2012 In small pilot study, some pediatric liver recipients come off immunosuppression
02-08-2012 Interferon and ribavirin control HCV genotype 6
01-18-2012 Four-drug therapy wiped out hepatitis C virus in most cases
01-13-2012 Rituximab helpful against HCV cryoglobulinemic vasculitis
01-06-2012 Adjuvant interferon doesn't prevent HCC recurrence
01-04-2012 Experimental hepatitis C vaccine shows early promise
01-03-2012 Aveo kidney cancer drug improves survival in late stage
01-02-2012 Stem cell preconditioning boosts liver volume before resection
12-29-2011 Combination therapy useful for advanced hepatoma
12-27-2011 Severe cryoglobulinemic vasculitis responds to rituximab therapy
12-23-2011 Bristol-Myers liver cancer drug brivanib fails phase III trial
11-11-2011 Pharmasset upbeat on drug for resistant hep C strain: CEO
11-10-2011 Stool color cards hasten referrals for biliary atresia
11-07-2011 Smallpox vaccine extends life in phase II hepatoma trial
09-29-2011 Vertex takes early rounds of hep C bout with Merck
09-07-2011 Adding telaprevir improves chronic hepatitis C therapy
09-06-2011 Pharmasset hep C drug shows promise in mid-stage trial
08-04-2011 Midodrine controls ascites, improves survival in cirrhotic patients
08-03-2011 Radiofrequency ablation a good option in early HCC, for some
07-28-2011 Perflubutane improves intra-op ultrasound diagnosis of HCC
07-26-2011 Vertex says combo hepatitis C treatment works
07-18-2011 Pitavastatin may enhance antivirals in some hepatitis C patients
06-03-2011 Renal effect of tenofovir is milder when it's used only for HBV
05-25-2011 Particle therapy promising in liver cancer
05-19-2011 Exelixis drug cabozantinib shown to control solid tumors
05-06-2011 Faster hepatitis B vaccine schedule has benefits in pregnancy
05-03-2011 Thiazolidinediones minor help in non-alcoholic steatohepatitis
05-02-2011 Advantages of stereotactic body radiation therapy remain questionable
04-28-2011 Selumetinib fails in HCC trial, minimally better in biliary cancer
04-27-2011 Telbivudine during pregnancy safely reduces vertical transmission of HBV
04-20-2011 Stereotactic radiotherapy helpful in colorectal liver metastases
04-12-2011 More immunogenic HBV vaccine regimens better in HIV-infected patients
04-12-2011 Vena cava clamping reduces hepatic resection blood loss
04-08-2011 High-intensity ultrasound gets high marks for HCC ablation
03-25-2011 Early liver biopsy important in alcoholic cirrhosis
03-15-2011 BCAAs won't prevent recurrent hepatic encephalopathy
03-10-2011 Low-dose interferon safe, effective for dialysis patients with hepatitis C
03-03-2011 Antiviral therapy lowers insulin resistance in HCV genotype 1 infection
02-28-2011 Rifaximin improves cognitive function in hepatic encephalopathy
02-24-2011 Adding telaprevir shortens HCV treatment for many
02-17-2011 Bevacizumab combo "encouraging" for advanced hepatoma
02-16-2011 Children with chronic hepatitis C respond well to peginterferon plus ribavirin
02-02-2011 Mycophenolate mofetil helps avoid steroids for autoimmune hepatitis
01-28-2011 Study finds no evidence black cohosh damages liver
01-26-2011 Peginterferon clears hepatitis D virus in nearly one quarter of cases
01-26-2011 Ambrisentan promising in portopulmonary hypertension
01-14-2011 Sanofi confirms liver damage in 2 Multaq patients
01-06-2011 No benefit from adjuvant bevacizumab for colon cancer metastases to liver
12-29-2010 Rifaximin improves cognition in minimal hepatic encephalopathy
12-22-2010 Cyanoacrylate injection advised for high-risk gastric varices
11-26-2010 Novel protease inhibitor active against hepatitis C
10-20-2010 Nonalcoholic steatohepatitis improves with pentoxifylline
10-18-2010 Roche hepatitis C drug appears safe in combination
09-08-2010 Telaprevir achieves SVR in toughest hepatitis C patients
08-23-2010 Hepatitis E vaccine appears effective in China trial
08-10-2010 Hep C protease inhibitor telaprevir works in 24 weeks: study
08-09-2010 Protease inhibitor improves treatment of hepatitis C
08-04-2010 Merck hepatitis C drug works; anemia seen
06-10-2010 Yttrium-90 radioembolization effective for neuroendocrine liver metastases
06-07-2010 Delcath sends melphalan directly into liver via hepatic artery
05-25-2010 Telaprevir achieves 75% rate of sustained HCV response: study
05-05-2010 Telaprevir improves sustained response rates in refractory HCV
04-29-2010 Octreotide shrinks polycystic livers and kidneys
04-21-2010 Metastatic melanoma trial meets main goal
04-21-2010 New compound potent against hepatitis C
04-16-2010 Gilead drug effective against liver disease: study
03-31-2010 Pegylated arginine deiminase has potential for unresectable hepatoma
02-24-2010 New hepatitis C drug shows good response in early trial
12-24-2009 Angiographic subsegmentectomy safe and effective for small liver tumors
12-03-2009 Hepatitis C drug fights virus in new way
08-18-2009 Sinovac says one-shot swine flu vaccine effective
08-14-2009 Glaxo starts testing flu pandemic vaccine
05-14-2009 Novel anti-HBV vaccine may prevent hepatocellular carcinoma
04-09-2009 AMD11070 shows action against X4-tropic HIV
03-09-2009 Human Genome hepatitis C drug disappoints, shares crash
12-25-2008 Silibinin infusion has antiviral effect against HCV in nonresponders
11-03-2008 Therapeutic hepatitis C vaccine shows benefit in phase 2 trial
08-22-2008 Silymarin prevents antituberculosis drug-related hepatotoxicity in rats
06-30-2008 Peptide vaccine shows some promise in hard-to-treat HCV
06-03-2008 IKK2 inhibition blocks liver steatosis in mice
04-30-2008 Radioembolization promising for inoperable chemorefractory liver metastases
12-03-2007 Fluoroscopy plus CT allows real-time evaluation of liver shunt placement
10-25-2007 Sunitinib shows promise against advanced hepatocellular carcinoma
09-20-2007 Hypermethylated DNA in circulation of patients with HBV predicts liver cancer
09-18-2007 Immune activator may make interferon-alpha more potent as HCV treatment
09-03-2007 Nano-coating of biliary stents prevents clogging
08-01-2007 Investigational antitumor agent nolatrexed fails in phase III study of liver cancer
05-15-2007 New HCV protease inhibitor effective against hepatitis C
03-27-2007 Fractalkine curbs metastatic colon cancer in mice
03-23-2007 Nitroflurbiprofen promising for cirrhotic portal hypertension
01-10-2007 Investigational agent reduces LDL cholesterol in familial hypercholesterolemia
11-13-2006 Radiolabeled antibodies kill HIV-1-infected cells
10-04-2006 Cyclophilin inhibitor acts against hepatitis C virus
07-13-2006 New blood test detects non-alcoholic steatohepatitis
07-10-2006 Statins may hold promise for chronic hepatitis C infection
05-22-2006 Hepatitis C protease inhibitor shows "dramatic" antiviral effects
05-01-2006 Human Genome says hepatitis C drug worked in combo
03-08-2006 Entecavir bests lamivudine for treatment of chronic hepatitis B
02-06-2006 Hepatitis C vaccine induces cellular immunity in chimpanzees
01-23-2006 Hepatitis C vaccine candidate shows promise in mice
12-05-2005 Radiation therapy improves outcome of unresectable hepatic cancer
11-01-2005 Entecavir safe, effective in lamivudine-refractory hepatitis B virus
08-29-2005 Oral fluid assay detects hepatitis B
05-17-2005 Vertex says investigational drug rapidly suppresses hepatitis C virus
05-10-2005 Vertex reports positive data for hepatitis C drug
02-14-2005 Potato vaccine immunogenic against hepatitis B
01-27-2005 Thalidomide of little value for advanced hepatocellular carcinoma
12-15-2004 Experimental vaccine effective in animal model of amebiasis
12-09-2004 Dynavax hepatitis B vaccine results encouraging in trial
11-15-2004 BILN 2061 impressively reduces HCV load but toxicity a concern
09-29-2004 New agent shows action against liver tumours
09-27-2004 Drug-releasing beads lower complications of chemotherapy in small trial
09-20-2004 Investigational drug fails to improve survival in melanoma metastasized to liver
06-29-2004 Microscience reports good phase I results with oral hepatitis B vaccine
06-23-2004 Plant-derived MAb to HBV surface antigen may provide treatment alternative
06-18-2004 Transcutaneous bilirubinometer may obviate most neonatal serum bilirubin tests
05-18-2004 Polymerase inhibitor safely reduced HCV viral load in humans: phase I/II trial
04-22-2004 Bioartificial liver improves survival in patients with severe hepatic failure
04-16-2004 Pegasys eradicates hepatitis B in some patients: Roche
03-25-2004 Fibrosis improved with hepatitis C vaccine, Innogenetics reports
03-18-2004 Antiretrovirus enzyme works against HBV
03-12-2004 Biomarker combination may noninvasively diagnose cirrhosis
03-02-2004 Roche says Pegasys can be tailored to hepatitis C genotype
02-10-2004 Radiolabeled tumor necrosis therapy shows strong binding in liver procedures
01-09-2004 Herbal derivative shown to accelerate bilirubin clearance in mice
12-24-2003 Drugs in development hold promise for patients with HIV and HBV coinfection
11-24-2003 Cuba produces key synthetic vaccine for children
10-28-2003 Roche's Pegasys shown advantageous for treatment of hepatitis B
10-27-2003 Hepatitis C protease inhibitor reduces viral load
09-02-2003 Risk data on Astra's Exanta deemed reassuring
09-01-2003 Assay detects hepatitis C antibody in oral fluids, dried blood spots
05-06-2003 Glove containing disinfectant may protect against viral infection
 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.